Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2.86M
-
Shares change
-
+18.5K
-
Total reported value, excl. options
-
$815K
-
Value change
-
-$630
-
Number of buys
-
6
-
Number of sells
-
-10
-
Price
-
$0.29
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2025
32 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2025.
IGC Pharma, Inc. - COM NEW (IGC) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.86M shares
.
Largest 10 shareholders include BlackRock, Inc. (704K shares), GEODE CAPITAL MANAGEMENT, LLC (700K shares), VANGUARD GROUP INC (645K shares), STATE STREET CORP (165K shares), Squarepoint Ops LLC (141K shares), NORTHERN TRUST CORP (113K shares), CITADEL ADVISORS LLC (94.5K shares), DEARBORN PARTNERS LLC (84.4K shares), GOLDMAN SACHS GROUP INC (65.5K shares), and TRUIST FINANCIAL CORP (36.7K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.